What Has Changed in Ebola Response Since the Last Big Outbreak
The tools available to fight Ebola look very different than they did during the 2014-2016 West Africa outbreak that killed more than 11,000 people, STAT News reports in its Morning Rounds roundup. Back then, responders had no licensed vaccine and no approved drugs. Today public health agencies can deploy Merck's Ervebo vaccine and antibody treatments cleared for use, changing how quickly a flare-up can be contained.
That shift matters because speed and supply now drive outcomes as much as case detection. A faster vaccination ring strategy and proven therapeutics give responders options that did not exist a decade ago, even as logistics, funding, and local trust remain hard problems.
The same STAT briefing surfaces two other stories worth watching: a federal report on alcohol that was suppressed before release, and what STAT calls an "inevitable" development in how data from consumer wearables will be collected and used. Both point to growing tension over who controls health information and how government findings reach the public.
Sources